Catalyst Wire Dossier Catalyst Wire Dossier

ASP0456

· Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ASP0456, covering 2011-01-20 to 2024-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome [Phase 3]

See pricing